Literature DB >> 7034765

Influence of agglutinating antibody in experimental cryptococcal meningitis.

J R Perfect, S D Lang, D T Durack.   

Abstract

A model for chronic Cryptococcus neoformans meningitis in corticosteroid-treated rabbits was used to determine the influence of pre-formed agglutinating antibody to cryptococcal polysaccharide on the progress of this infection. Immunized rabbits developed serum agglutinating antibody with a geometric mean titre of 1:32, but none was detected in cerebrospinal fluid. Prior immunization did not enhance immunity to infection, had no effect on the number of viable cryptococci in cerebrospinal fluid, and did not prevent dissemination outside the central nervous system. Future investigations in this field should focus on cellular rather than humoral defence mechanisms.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7034765      PMCID: PMC2041737     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  10 in total

1.  Passive immunization against Cryptococcus neoformans.

Authors:  H H GADEBUSCH
Journal:  Proc Soc Exp Biol Med       Date:  1958-07

2.  Passively-acquired immunity in experimental cryptococcosis.

Authors:  D B Louria; T Kaminski
Journal:  Sabouraudia       Date:  1965-06

3.  Prognostic factors in cryptococcal meningitis. A study in 111 cases.

Authors:  R D Diamond; J E Bennett
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

4.  Determination of total and merecaptothanol-resistant antibody in the same serum sample.

Authors:  D W Scott; R K Gershon
Journal:  Clin Exp Immunol       Date:  1970-02       Impact factor: 4.330

5.  Experimental murine cryptococcosis: effect of hyperimmunization to capsular polysaccharide.

Authors:  M B Goren
Journal:  J Immunol       Date:  1967-05       Impact factor: 5.422

6.  Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans.

Authors:  R D Diamond; A C Allison
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

7.  Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis.

Authors:  K G Porter; D G Sinnamon; R R Gillies
Journal:  Lancet       Date:  1977-06-11       Impact factor: 79.321

8.  Cryptococcosis after renal transplantation: report of ten cases.

Authors:  G P Schröter; D R Temple; B S Husberg; R Weil; T E Starzl
Journal:  Surgery       Date:  1976-03       Impact factor: 3.982

9.  Chronic cryptococcal meningitis: a new experimental model in rabbits.

Authors:  J R Perfect; S D Lang; D T Durack
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

10.  Experimental cryptococcosis in normal and B-cell-deficient mice.

Authors:  D P Monga; R Kumar; L N Mohapatra; A N Malaviya
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

  10 in total
  10 in total

1.  Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide.

Authors:  J E Sanford; D M Lupan; A M Schlageter; T R Kozel
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis.

Authors:  M M Hobbs; J R Perfect; D L Granger; D T Durack
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

Review 3.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

4.  Effects of cyclosporine in experimental cryptococcal meningitis.

Authors:  J R Perfect; D T Durack
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

5.  Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid.

Authors:  J R Perfect; D L Toffaletti; T H Rude
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody.

Authors:  F Dromer; J Charreire; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

8.  Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans.

Authors:  N Nabavi; J W Murphy
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

9.  Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat.

Authors:  D Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.

Authors:  D L Granger; J R Perfect; D T Durack
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.